Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Erectile Dysfunction

  Free Subscription


Articles published in J Urol

Retrieve available abstracts of 173 articles:
HTML format



Single Articles


    August 2021
  1. TOUSSI A, Ziegelmann M, Yang D, Manka M, et al
    Efficacy of a Novel Penile Traction Device in Improving Penile Length and Erectile Function Post Prostatectomy: Results from a Single-Center Randomized, Controlled Trial.
    J Urol. 2021;206:416-426.
    PubMed     Abstract available


  2. KUMAR RM, Fergusson DA, Lavallee LT, Cagiannos I, et al
    Performance Feedback May Not Improve Radical Prostatectomy Outcomes: The Surgical Report Card (SuRep) Study.
    J Urol. 2021;206:346-353.
    PubMed     Abstract available


    July 2021
  3. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2021;206:141-144.
    PubMed    


    June 2021
  4. PATEL HD, Schwen ZR, Campbell JD, Gorin MA, et al
    Effect of Erythropoietin on Erectile Function after Radical Prostatectomy: The ERECT Randomized Clinical Trial.
    J Urol. 2021;205:1681-1688.
    PubMed     Abstract available


    April 2021
  5. LEYH-BANNURAH SR, Liakos N, Oelke M, Wagner C, et al
    Peri- and Postoperative Outcomes of Robot-Assisted Radical Prostatectomy in Prostate Cancer Patients with Prior Transurethral Subvesical Deobstruction: Results of a High-Volume Center.
    J Urol. 2021 Apr 27:101097JU0000000000001776. doi: 10.1097/JU.0000000000001776.
    PubMed     Abstract available


  6. MCVARY KT, Gittelman MC, Goldberg KA, Patel K, et al
    Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of Rezum Water Vapor Thermal Therapy for Treatment of Moderate-To-Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    J Urol. 2021 Apr 19:101097JU0000000000001778. doi: 10.1097/JU.0000000000001778.
    PubMed     Abstract available


  7. SARI MOTLAGH R, Abufaraj M, Yang L, Mori K, et al
    Penile Rehabilitation Strategy after Nerve Sparing Radical Prostatectomy: A Systematic Review and Network Meta-Analysis of Randomized Trials.
    J Urol. 2021;205:1018-1030.
    PubMed     Abstract available


    March 2021
  8. UMARI P, Eden C, Cahill D, Rizzo M, et al
    Retzius-Sparing versus Standard Robot-Assisted Radical Prostatectomy: A Comparative Prospective Study of Nearly 500 Patients.
    J Urol. 2021;205:780-790.
    PubMed     Abstract available


    February 2021
  9. STAHL PJ, Millheiser L, Carroll P
    Evaluation of Online Telehealth Platforms for Treatment of Erectile Dysfunction. Letter.
    J Urol. 2021 Feb 16:101097JU0000000000001681. doi: 10.1097/JU.0000000000001681.
    PubMed    


  10. HSIANG W, Honig S, Leapman M
    Evaluation of Online Telehealth Platforms for Treatment of Erectile Dysfunction. Reply.
    J Urol. 2021 Feb 16:101097JU0000000000001682. doi: 10.1097/JU.0000000000001682.
    PubMed    


    January 2021
  11. SEFTEL AD
    Male and Female Sexual Function and Dysfunction; Andrology.
    J Urol. 2021;205:287-290.
    PubMed    


    December 2020
  12. PYRGIDIS N, Mykoniatis I, Sokolakis I, Minopoulou I, et al
    Renal Transplantation Improves Erectile Function in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis.
    J Urol. 2020 Dec 15:101097JU0000000000001577. doi: 10.1097/JU.0000000000001577.
    PubMed     Abstract available


  13. SEFTEL AD
    Re: Risk Profiling in Patients Undergoing Penile Prosthesis Implantation.
    J Urol. 2020;204:1364.
    PubMed    


    November 2020
  14. REZAEE ME, Towe M, Osman MM, Huynh LM, et al
    A Multicenter Investigation Examining American Urological Association Recommended Antibiotic Prophylaxis vs Nonstandard Prophylaxis in Preventing Device Infections in Penile Prosthesis Surgery in Diabetic Patients.
    J Urol. 2020;204:969-975.
    PubMed     Abstract available


  15. MASTERSON TA, Parmar M, Tradewell MB, Nackeeran S, et al
    Using Artificial Intelligence to Predict Surgical Shunts in Men with Ischemic Priapism.
    J Urol. 2020;204:1033-1038.
    PubMed     Abstract available


  16. SEFTEL AD
    Re: Effect of Intensive vs Standard Blood Pressure Treatment upon Erectile Function in Hypertensive Men: Findings from the Systolic Blood Pressure Intervention Trial.
    J Urol. 2020;204:1080.
    PubMed    


    October 2020
  17. FAINBERG J, Gaffney CD, Pierce H, Aboukhshaba A, et al
    Erectile Dysfunction is a Transient Complication of Prostate Biopsy: A Systematic Review and Metanalysis.
    J Urol. 2020 Oct 7:101097JU0000000000001398. doi: 10.1097/JU.0000000000001398.
    PubMed     Abstract available


  18. SEFTEL AD
    Re: What is a "Validated Questionnaire"? A Critical Review of Erectile Function Assessment.
    J Urol. 2020;204:862.
    PubMed    


  19. SEFTEL AD
    Re: The Use of Penile Computed Tomography Cavernosogram in the Evaluation of Peyronie's Disease: A Pilot Study.
    J Urol. 2020;204:861.
    PubMed    


    September 2020
  20. SEFTEL AD
    Re: Color Doppler Duplex Ultrasound Parameters in Men without Organic Erectile Dysfunction.
    J Urol. 2020 Sep 22:101097JU0000000000001274. doi: 10.1097/JU.0000000000001274.
    PubMed    


  21. GRIEBLING TL
    Re: The Relationship between Gait Function and Erectile Dysfunction: Results from a Community-Based Cross-Sectional Study in Japan.
    J Urol. 2020 Sep 22:101097JU000000000000127001.
    PubMed    


  22. HSIANG WR, Honig S, Leapman MS
    Evaluation of Online Telehealth Platforms for Treatment of Erectile Dysfunction.
    J Urol. 2020 Sep 18:101097JU0000000000001378. doi: 10.1097/JU.0000000000001378.
    PubMed    


  23. CALZO JP, Austin SB, Charlton BM, Missmer S, et al
    Erectile Dysfunction in a Sample of Sexually Active Young Adult Men from a US Cohort: Demographic, Metabolic, and Mental Health Correlates.
    J Urol. 2020 Sep 16:101097JU0000000000001367. doi: 10.1097/JU.0000000000001367.
    PubMed     Abstract available


  24. SEFTEL AD
    Re: A Cost-Utility Analysis of Phosphodiesterase Type 5 Inhibitors in the Treatment of Erectile Dysfunction.
    J Urol. 2020 Sep 8:101097JU0000000000001252. doi: 10.1097/JU.0000000000001252.
    PubMed    


  25. SEFTEL AD
    Re: Epidemiology and Treatment Barriers of Patients with Erectile Dysfunction Using an Online Prescription Platform: A Cross-Sectional Study.
    J Urol. 2020 Sep 8:101097JU000000000000125201.
    PubMed    


  26. SEFTEL AD
    Re: Efficacy and Tolerability of Sildenafil/L-Arginine Combination Relative to Sildenafil Alone in Patients with Organic Erectile Dysfunction.
    J Urol. 2020 Sep 8:101097JU000000000000125202.
    PubMed    


    August 2020
  27. ELLIOTT SP
    Re: Tighter Blood Pressure Control is Associated with Lower Incidence of Erectile Dysfunction in Hypertensive Men.
    J Urol. 2020 Aug 21:101097JU0000000000001257. doi: 10.1097/JU.0000000000001257.
    PubMed    


  28. BORGES RC, Tourinho-Barbosa RR, Glina S, Macek P, et al
    Impact of Focal Versus Whole Gland Ablation for Prostate Cancer on Sexual Function and Urinary Continence.
    J Urol. 2020 Aug 17:101097JU0000000000001327. doi: 10.1097/JU.0000000000001327.
    PubMed     Abstract available


  29. SEFTEL AD
    Re: Inflatable Penile Prosthesis in the Ambulatory Surgical Setting: Outcomes from a Large Urological Group Practice.
    J Urol. 2020;204:369.
    PubMed    


    July 2020
  30. KAPLAN SA
    Re: The Independent Association of Non-Alcoholic Fatty Liver Disease with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and Erectile Function Scores.
    J Urol. 2020 Jul 22:101097JU000000000000120501.
    PubMed    


    June 2020
  31. SEFTEL AD
    Re: Placebo Responses among Men with Erectile Dysfunction Enrolled in Phosphodiesterase 5 Inhibitor Trials: A Systematic Review and Meta-Analysis.
    J Urol. 2020 Jun 26:101097JU000000000000116702.
    PubMed    


  32. SEFTEL AD
    Re: The Combined Use of Stem Cells and Platelet Lysate Plasma for the Treatment of Erectile Dysfunction: A Pilot Study-6 Months Results.
    J Urol. 2020 Jun 26:101097JU000000000000116701.
    PubMed    


  33. SEFTEL AD
    Re: Erectile Dysfunction and Cardiovascular Risk: A Review of Current Findings.
    J Urol. 2020 Jun 26:101097JU000000000000116704.
    PubMed    


  34. SEFTEL AD
    Re: The Daily Therapy with L-Arginine 2,500 mg and Tadalafil 5 mg in Combination and in Monotherapy for the Treatment of Erectile Dysfunction: A Prospective, Randomized Multicentre Study.
    J Urol. 2020 Jun 26:101097JU000000000000116703.
    PubMed    


    May 2020
  35. SEFTEL AD
    Re: Updating the International Index of Erectile Function: Evaluation of a Large Clinical Data Set.
    J Urol. 2020;203:863.
    PubMed    


    April 2020
  36. SEFTEL AD
    Re: Correlation between Internal Pudendal Artery Stenosis and Erectile Dysfunction in Patients with Suspected Coronary Artery Disease.
    J Urol. 2020 Apr 15:101097JU000000000000104701.
    PubMed    


  37. SEFTEL AD
    Re: Is Topical Alprostadil an Usable and Reliable Alternative to Intracavernous Injection for Penile Dynamic Duplex Ultrasonography?
    J Urol. 2020 Apr 15:101097JU000000000000104702.
    PubMed    


  38. SEFTEL AD
    Re: Paternity, Erectile Function, and Health-Related Quality of Life in Patients Operated for Pediatric Testicular Torsion.
    J Urol. 2020 Apr 15:101097JU0000000000001047. doi: 10.1097/JU.0000000000001047.
    PubMed    


    March 2020
  39. SEFTEL AD
    Re: Association of Erectile Dysfunction with Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA).
    J Urol. 2020 Mar 18:101097JU000000000000099104.
    PubMed    


  40. SEFTEL AD
    Re: Electromagnetic Low-Intensity Extracorporeal Shock Wave Therapy in Patients with Erectile Dysfunction: A Sham-Controlled, Double-Blind, Randomized Prospective Study.
    J Urol. 2020 Mar 18:101097JU000000000000099103.
    PubMed    


  41. SEFTEL AD
    Re: Relationship between Cannabis Use and Erectile Dysfunction: A Systematic Review and Meta-Analysis.
    J Urol. 2020 Mar 18:101097JU0000000000000991. doi: 10.1097/JU.0000000000000991.
    PubMed    


  42. SEFTEL AD
    Re: Utility of Dynamic MRA in the Evaluation of Male Erectile Dysfunction.
    J Urol. 2020 Mar 18:101097JU000000000000099101.
    PubMed    


  43. SEFTEL AD
    Re: Long-Term Follow-up after Penile Prosthesis Implantation-Survival and Quality of Life Outcomes.
    J Urol. 2020;203:448.
    PubMed    


  44. SEFTEL AD
    Re: High-Submuscular vs. Space of Retzius Reservoir Placement during Implantation of Inflatable Penile Implants.
    J Urol. 2020;203:448-449.
    PubMed    


    February 2020
  45. SEFTEL AD
    Re: An Open-Label, Single-Arm Pilot Study to Evaluate the Efficacy of Daily Low Dose Tadalafil on Depression in Patients with Erectile Dysfunction.
    J Urol. 2020 Feb 13:101097JU000000000000076903.
    PubMed    


  46. SEFTEL AD
    Re: Incidental Findings during Computed Tomographic Angiography Diagnostic Work-up in Patients with Arteriogenic Erectile Dysfunction.
    J Urol. 2020 Feb 13:101097JU000000000000076904.
    PubMed    


  47. SEFTEL AD
    Re: Infectious Adverse Events following the Placement of a Penile Prosthesis: A Systematic Review.
    J Urol. 2020;203:237.
    PubMed    


  48. MOREY AF
    Re: Selective Penile Arterial Embolization Preserves Long-Term Erectile Function in Patients with Nonischemic Priapism: An 18-Year Experience.
    J Urol. 2020;203:244-245.
    PubMed    


  49. SEFTEL AD
    Re: Development of Nomograms to Predict the Recovery of Erectile Function following Radical Prostatectomy.
    J Urol. 2020;203:236.
    PubMed    


    January 2020
  50. ZHOU CK, Advani S, Chaloux M, Gibson JT, et al
    Trends and Patterns of Testosterone Therapy Among US Male Medicare Beneficiaries, 1999-2014.
    J Urol. 2020 Jan 13:101097JU0000000000000744. doi: 10.1097/JU.0000000000000744.
    PubMed     Abstract available


  51. LEE J, Kim HY, Goh HJ, Heo JE, et al
    Retzius Sparing Robot-Assisted Radical Prostatectomy Conveys Early Regain of Continence over Conventional Robot-Assisted Radical Prostatectomy: A Propensity Score Matched Analysis of 1,863 Patients.
    J Urol. 2020;203:137-144.
    PubMed     Abstract available


    December 2019
  52. SEFTEL AD
    Re: Relation between Mitral Valve Prolapse and Erectile Dysfunction (from a Nationwide Case-Control Study).
    J Urol. 2019 Dec 10:101097JU0000000000000668. doi: 10.1097/JU.0000000000000668.
    PubMed    


  53. SEFTEL AD
    Re: Current Strategies in the Management of Peyronie's Disease (PD)-Results of a Survey of 401 Sexual Medicine Experts across Europe.
    J Urol. 2019;202:1080-1081.
    PubMed    


    November 2019
  54. ABOLAZM AE, El-Hefnawy AS, Laymon M, Shehab-El-Din AB, et al
    Ejaculatory Hood Sparing vs. Standard GreenLight(TM) Laser Photoselective Vaporization of the Prostate: Sexual and Urodynamic Assessment Through Double Blinded Randomized Trial.
    J Urol. 2019 Nov 25:101097JU0000000000000685. doi: 10.1097/JU.0000000000000685.
    PubMed     Abstract available


  55. SEFTEL AD
    Re: Association of Concussion Symptoms with Testosterone Levels and Erectile Dysfunction in Former Professional US-Style Football Players.
    J Urol. 2019 Nov 11:101097JU0000000000000647. doi: 10.1097/JU.0000000000000647.
    PubMed    


  56. SEFTEL AD
    Re: An Evaluation of a Clinical Care Pathway for the Management of Men with Nonorganic Erectile Dysfunction.
    J Urol. 2019 Nov 11:10109701JU0000614816797488.
    PubMed    


  57. GRIEBLING TL
    Re: The Rate of Deterioration of Erectile Function Increases with Age: Results from a Longitudinal Population Based Survey.
    J Urol. 2019;202:845.
    PubMed    


    September 2019
  58. SEFTEL AD
    Re: Older Age and a Large Tunical Tear May be Predictors of Increased Erectile Dysfunction Rates following Penile Fracture Surgery.
    J Urol. 2019 Sep 12:101097JU0000000000000546. doi: 10.1097/JU.0000000000000546.
    PubMed    


  59. SEFTEL AD
    Re: The Influence of Internal Iliac Artery Occlusion after Endovascular Abdominal Aneurysm Repair on Buttock Claudication and Erectile Dysfunction: A Matched Case-Control Study.
    J Urol. 2019 Sep 12:10109701JU000058518868066.
    PubMed    


  60. ZIEGELMANN M, Savage J, Toussi A, Alom M, et al
    Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial.
    J Urol. 2019;202:599-610.
    PubMed     Abstract available


    July 2019
  61. SEFTEL AD
    Re: Erectile Dysfunction in 45-Year-Old Heterosexual German Men and Associated Lifestyle Risk Factors and Comorbidities: Results from the German Male Sex Study.
    J Urol. 2019 Jul 26:10109701JU00005788766479142.
    PubMed    


  62. SEFTEL AD
    Re: Low-Intensity Shockwave Therapy (LiST) for Erectile Dysfunction: Is it Safe for Patients on Anticoagulant Medication?
    J Urol. 2019 Jul 26:101097JU0000000000000469. doi: 10.1097/JU.0000000000000469.
    PubMed    


  63. SEFTEL AD
    Re: Self-Regulation in the Pharmaceutical Industry: The Exposure of Children and Adolescents to Erectile Dysfunction Commercials.
    J Urol. 2019 Jul 26:10109701JU000057886819049.
    PubMed    


  64. GRIEBLING TL
    Re: Sexual Dysfunction and Bother Due to Erectile Dysfunction in the Healthy Elderly Male Population: Prevalence from a Systematic Review.
    J Urol. 2019 Jul 26:10109701JU000057892445973.
    PubMed    


  65. SEFTEL AD
    Re: Epidemiologic Profile of Erectile Dysfunction in Patients with Systemic Lupus Erythematosus: The Latin American Landscape.
    J Urol. 2019 Jul 9:10109701JU000057695203188.
    PubMed    


  66. SEFTEL AD
    Re: Erectile Dysfunction in 45-Year-Old Heterosexual German Men and Associated Lifestyle Risk Factors and Comorbidities: Results from the German Male Sex Study.
    J Urol. 2019 Jul 9:10109701JU00005769568031636.
    PubMed    


  67. SEFTEL AD
    Re: Sub-External Oblique Placement of Inflatable Penile Prosthesis Reservoirs-Initial Experience.
    J Urol. 2019;202:14.
    PubMed    


    June 2019
  68. SEFTEL AD
    Re: Endovascular Therapy for Erectile Dysfunction-Who Benefits Most? Insights from a Single-Center Experience.
    J Urol. 2019 Jun 20:10109701JU0000574452612637.
    PubMed    


  69. SEFTEL AD
    Re: Erectile Dysfunction Medications and Skin Cancer: An Analysis in US Veterans.
    J Urol. 2019 Jun 20:10109701JU00005744566888619.
    PubMed    


  70. SEFTEL AD
    Re: Impact of Pelvic Radiation Therapy on Inflatable Penile Prosthesis Reoperation Rates.
    J Urol. 2019;201:1036-1037.
    PubMed    


  71. MOREY AF
    Re: Penile Sensory Changes after Plaque Incision and Grafting Surgery for Peyronie's Disease.
    J Urol. 2019;201:1046-1047.
    PubMed    


    May 2019
  72. SEFTEL AD
    Re: Tighter Blood Pressure Control is Associated with Lower Incidence of Erectile Dysfunction in Hypertensive Men.
    J Urol. 2019 May 7:10109701JU000055962970617.
    PubMed    


  73. SEFTEL AD
    Re: Erectile Dysfunction is Highly Prevalent in Men with Newly Diagnosed Inflammatory Bowel Disease.
    J Urol. 2019 May 7:10109701JU00005596272487625.
    PubMed    


  74. SEFTEL AD
    Re: Chronic Administration of LIMK2 Inhibitors Alleviates Cavernosal Veno-Occlusive Dysfunction through Suppression of Cavernosal Fibrosis in a Rat Model of Erectile Dysfunction after Cavernosal Nerve Injury.
    J Urol. 2019 May 7:10109701JU0000559626477475.
    PubMed    


  75. SEFTEL AD
    Re: Updated Evidence of Association between Periodontal Disease and Incident Erectile Dysfunction.
    J Urol. 2019;201:841.
    PubMed    


  76. SEFTEL AD
    Re: Erectile Dysfunction Severity as a Predictor of Left Main and/or Three-Vessel Disease in Acute Coronary Syndrome Patients.
    J Urol. 2019;201:842-843.
    PubMed    


  77. SEFTEL AD
    Re: Penile Prosthesis Reservoir Removal: Surgical Description and Patient Outcomes.
    J Urol. 2019;201:842.
    PubMed    


  78. MOREY AF
    Re: Penoscrotal versus Minimally Invasive Infrapubic Approach for Inflatable Penile Prosthesis Placement: A Single-Center Matched-Pair Analysis.
    J Urol. 2019;201:852.
    PubMed    


    April 2019
  79. SEFTEL AD
    Re: Penile Sensory Changes after Plaque Incision and Grafting Surgery for Peyronie's Disease.
    J Urol. 2019;201:650.
    PubMed    


    March 2019
  80. ATALA A
    Re: Genetic Variation in the SIM1 Locus is Associated with Erectile Dysfunction.
    J Urol. 2019 Mar 13:101097JU0000000000000215. doi: 10.1097/JU.0000000000000215.
    PubMed    


  81. COWARD RM, Stetter C, Kunselman A, Trussell JC, et al
    Fertility-Related Quality of Life, Gonadal Function, and Erectile Dysfunction in Male Partners of Couples with Unexplained Infertility.
    J Urol. 2019 Mar 5:101097JU0000000000000205. doi: 10.1097/JU.0000000000000205.
    PubMed     Abstract available


  82. SEFTEL AD
    Re: Bibliometric Analysis of Erectile Dysfunction Publications in Urology and Sexual Medicine Journals.
    J Urol. 2019;201:425.
    PubMed    


  83. SEFTEL AD
    Re: Treatment for Erectile Dysfunction among Older Men in Northern Ireland.
    J Urol. 2019;201:424.
    PubMed    


  84. KAPLAN SA
    Re: Long-Term Dutasteride Therapy in Men with Benign Prostatic Hyperplasia Alters Glucose and Lipid Profiles and Increases Severity of Erectile Dysfunction.
    J Urol. 2019;201:416-417.
    PubMed    


  85. HERNANDEZ JC, Trost L, Kohler T, Ring J, et al
    Emerging Complications Following Alternative Reservoir Placement during Inflatable Penile Prosthesis Placement: A 5-Year Multi-Institutional Experience.
    J Urol. 2019;201:581-586.
    PubMed     Abstract available


    February 2019
  86. MOREY AF
    Re: Risk Stratification for Erectile Dysfunction after Pelvic Fracture Urethral Injuries.
    J Urol. 2019 Feb 15:10109701JU0000554199667014.
    PubMed    


  87. SEFTEL AD
    Re: A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Utility of Tacrolimus (FK506) for the Prevention of Erectile Dysfunction following Bilateral Nerve-Sparing Radical Prostatectomy.
    J Urol. 2019;201:212.
    PubMed    


  88. SEFTEL AD
    Re: Alcohol Intake and Risk of Erectile Dysfunction: .
    J Urol. 2019;201:212.
    PubMed    


  89. SEFTEL AD
    Re: The Risk of Erectile Dysfunction following Pelvic Angiographic Embolization in Pelvic Fracture Patients: .
    J Urol. 2019;201:211-212.
    PubMed    


  90. SEFTEL AD
    Re: The Masturbation Erection Index (MEI): .
    J Urol. 2019;201:210-211.
    PubMed    


    January 2019
  91. SEFTEL AD
    Re: Biomechanical Comparison of Inflatable Penile Implants: A Cadaveric Pilot Study.
    J Urol. 2019;201:15.
    PubMed    


  92. PATEL N, Golan R, Halpern JA, Sun T, et al
    A Contemporary Analysis of Dual Inflatable Penile Prosthesis and Artificial Urinary Sphincter Outcomes.
    J Urol. 2019;201:141-146.
    PubMed     Abstract available


    November 2018
  93. KAPLAN SA
    Re: Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
    J Urol. 2018;200:918-921.
    PubMed    


    October 2018
  94. SEFTEL AD
    Re: Real-World Observational Results from a Database of 48 Million Men in the United States: Relationship of Cardiovascular Disease, Diabetes Mellitus and Depression with Age and Erectile Dysfunction.
    J Urol. 2018;200:680-682.
    PubMed    


    September 2018
  95. CHAPMAN DW, Cotter K, Johnsen NV, Patel S, et al
    Non-Transecting Techniques Reduce Sexual Dysfunction After Anastomotic Bulbar Urethroplasty: Results of a Multi-Institutional Comparative Analysis.
    J Urol. 2018 Sep 25. pii: S0022-5347(18)43945-6. doi: 10.1016/j.juro.2018.
    PubMed     Abstract available


  96. SEFTEL AD
    Re: The Effect of Low-Intensity Extracorporeal Shockwave Therapy in an Obesity-Associated Erectile Dysfunction Rat Model.
    J Urol. 2018;200:482.
    PubMed    


  97. SEFTEL AD
    Re: Abnormal Brain Structure as a Potential Biomarker for Venous Erectile Dysfunction: Evidence from Multimodal MRI and Machine Learning.
    J Urol. 2018;200:481-482.
    PubMed    


  98. SEFTEL AD
    Re: Efficacy and Safety of Tadalafil 5 mg Once Daily for the Treatment of Erectile Dysfunction after Robot-Assisted Laparoscopic Radical Prostatectomy: A 2-Year Follow-up.
    J Urol. 2018;200:481.
    PubMed    


  99. SEFTEL AD
    Re: The Role of Neutrophil-to-Lymphocyte Ratio in Men with Erectile Dysfunction-Preliminary Findings of a Real-Life Cross-Sectional Study.
    J Urol. 2018;200:480-482.
    PubMed    


    July 2018
  100. LOPATEGUI DM, Balise RR, Bouzoubaa LA, Wilson SK, et al
    The Impact of Immediate Salvage Surgery on Corporeal Length Preservation in Patients Presenting with Penile Implant Infections.
    J Urol. 2018;200:171-177.
    PubMed     Abstract available


    June 2018
  101. SEFTEL AD
    Re: Efficacy and Safety of MED2005, a Topical Glyceryl Trinitrate Formulation, in the Treatment of Erectile Dysfunction: A Randomized Crossover Study.
    J Urol. 2018;199:1378-1380.
    PubMed    


    May 2018
  102. BURNETT AL, Nehra A, Breau RH, Culkin DJ, et al
    Erectile Dysfunction: AUA Guideline.
    J Urol. 2018 May 7. pii: S0022-5347(18)43100-X. doi: 10.1016/j.juro.2018.
    PubMed     Abstract available


  103. BANDAK M, Lauritsen J, Johansen C, Kreiberg M, et al
    Sexual function in a nationwide cohort of 2260 testicular cancer survivors after 17 years follow-up.
    J Urol. 2018 May 3. pii: S0022-5347(18)43080-7. doi: 10.1016/j.juro.2018.
    PubMed     Abstract available


  104. SEFTEL AD
    Re: Erectile Dysfunction and Quality of Life in Men Receiving Methadone or Buprenorphine Maintenance Treatment. A Cross-Sectional Multicentre Study.
    J Urol. 2018;199:1095-1097.
    PubMed    


    March 2018
  105. KOHLER TS
    Editorial Comment.
    J Urol. 2018;199:810-811.
    PubMed    


    February 2018
  106. KITREY ND, Vardi Y, Appel B, Shechter A, et al
    Low-intensity shockwave treatment for erectile dysfunction - how long does the effect last?
    J Urol. 2018 Feb 22. pii: S0022-5347(18)39376-5. doi: 10.1016/j.juro.2018.
    PubMed     Abstract available


  107. SEFTEL AD
    Re: Quality of Erections by Age Group in Men with Erectile Dysfunction.
    J Urol. 2018;199:328.
    PubMed    


  108. SEFTEL AD
    Re: Prognostic Value of Exercise Capacity among Men Undergoing Pharmacologic Treatment for Erectile Dysfunction: The FIT Project.
    J Urol. 2018;199:327-329.
    PubMed    


    January 2018
  109. SEFTEL AD
    Re: Long-Term Outcomes of AMS Spectra(R) Penile Prosthesis Implantation and Satisfaction Rates.
    J Urol. 2018;199:15-16.
    PubMed    


  110. SEFTEL AD
    Re: Inflatable Penile Prosthesis as Tissue Expander: What is the Evidence?
    J Urol. 2018;199:15.
    PubMed    


    December 2017
  111. SEFTEL AD
    Re: Factors Associated with Erectile Dysfunction and the Peyronie's Disease Questionnaire in Patients with Peyronie Disease.
    J Urol. 2017;198:1193-1194.
    PubMed    


  112. SEFTEL AD
    Re: Does any Association Exist between Chronic Obstructive Pulmonary Disease and Erectile Dysfunction? The DECODED Study.
    J Urol. 2017;198:1192-1194.
    PubMed    


  113. MOREY AF
    Re: The Effect of Urethral Transection on Erectile Function after Anterior Urethroplasty.
    J Urol. 2017;198:1202.
    PubMed    


    November 2017
  114. SEFTEL AD
    Re: Low-Intensity Shockwave Therapy Improves Hemodynamic Parameters in Patients with Vasculogenic Erectile Dysfunction: A Triplex Ultrasonography-Based Sham-Controlled Trial.
    J Urol. 2017;198:964.
    PubMed    


  115. SEFTEL AD
    Re: Male Sexual Function in New Zealand: A Population-Based Cross-Sectional Survey of the Prevalence of Erectile Dysfunction in Men Aged 40-70 Years.
    J Urol. 2017;198:963-965.
    PubMed    


    September 2017
  116. KAPLAN SA
    Re: Impact of Combination Therapy 5-Alpha Reductase Inhibitors (5-ARI) plus Alpha-Blockers (AB) on Erectile Dysfunction and Decrease of Libido in Patients with LUTS/BPH: A Systematic Review with Meta-Analysis.
    J Urol. 2017;198:457-458.
    PubMed    


  117. KAPLAN SA
    Re: A Prospective Longitudinal Survey of Erectile Function Status in Symptomatic Benign Prostatic Hyperplasia Patients Treated with Dutasteride.
    J Urol. 2017;198:459.
    PubMed    


    August 2017
  118. SEFTEL AD
    Re: Combination of Mesenchymal Stem Cell Injection with Icariin for the Treatment of Diabetes-Associated Erectile Dysfunction.
    J Urol. 2017;198:238.
    PubMed    


  119. SEFTEL AD
    Re: Subclinical Vascular Disease and Subsequent Erectile Dysfunction: The Multiethnic Study of Atherosclerosis (MESA).
    J Urol. 2017;198:236-237.
    PubMed    


  120. SEFTEL AD
    Re: Association between Treatment for Erectile Dysfunction and Death or Cardiovascular Outcomes after Myocardial Infarction.
    J Urol. 2017;198:236-238.
    PubMed    


  121. SEFTEL AD
    Re: Relationship between Age and Erectile Dysfunction Diagnosis or Treatment Using Real-World Observational Data in the USA.
    J Urol. 2017;198:235-236.
    PubMed    


  122. SEFTEL AD
    Re: Validity of Premature Ejaculation Diagnostic Tool and its Association with International Index of Erectile Function-15 in Chinese Men with Evidence-Based-Defined Premature Ejaculation.
    J Urol. 2017;198:237-238.
    PubMed    


    July 2017
  123. YANG L, Kibel AS, Colditz GA, Pakpahan R, et al
    Caution with Use of the Expanded Prostate Cancer Index Composite-50 Urinary Bother Scale: How Voiding Dysfunction Modifies Its Performance.
    J Urol. 2017 Jul 17. pii: S0022-5347(17)77147-9. doi: 10.1016/j.juro.2017.
    PubMed     Abstract available


    June 2017
  124. SEFTEL AD
    Re: Self-Reported Sitting Time and Prevalence of Erectile Dysfunction in Japanese Patients with Type 2 Diabetes Mellitus: The Dogo Study.
    J Urol. 2017;197:1534.
    PubMed    


  125. SEFTEL AD
    Re: Skin Autofluorescence (a Marker for Advanced Glycation End Products) and Erectile Dysfunction in Diabetes.
    J Urol. 2017;197:1533-1535.
    PubMed    


  126. SEFTEL AD
    Re: Rasch Analysis of the Premature Ejaculation Diagnostic Tool (PEDT) and the International Index of Erectile Function (IIEF) in an Iranian Sample of Prostate Cancer Patients.
    J Urol. 2017;197:1534-1535.
    PubMed    


    May 2017
  127. SEFTEL AD
    Re: Prevalence of Use of Erectile Dysfunction Medication by Dutch Military Personnel between 2003 and 2012.
    J Urol. 2017;197:1333.
    PubMed    


    March 2017
  128. SEFTEL AD
    Re: Mirabegron Causes Relaxation of Human and Rat Corpus Cavernosum: Could it be a Potential Therapy for Erectile Dysfunction?
    J Urol. 2017;197.
    PubMed    


    February 2017
  129. ATALA A
    Re: Treatment of Diabetes Mellitus-Induced Erectile Dysfunction Using Endothelial Progenitor Cells Genetically Modified with Human Telomerase Reverse Transcriptase.
    J Urol. 2017;197:494.
    PubMed    


    January 2017
  130. KAPLAN SA
    Re: Finasteride, Not Tamsulosin, Increases Severity of Erectile Dysfunction and Decreases Testosterone Levels in Men with Benign Prostatic Hyperplasia.
    J Urol. 2017;197:221-222.
    PubMed    


    December 2016
  131. WALSH PC, Donker PJ
    Impotence Following Radical Prostatectomy: Insight into Etiology and Prevention.
    J Urol. 2016 Dec 21. pii: S0022-5347(16)31658-5. doi: 10.1016/j.juro.2016.
    PubMed     Abstract available


  132. BURNETT AL
    Impotence after Radical Prostatectomy.
    J Urol. 2016 Dec 20. pii: S0022-5347(16)31721-9. doi: 10.1016/j.juro.2016.
    PubMed    


  133. NANGIA AK
    Testosterone Replacement Should be Given to Men with Erectile Dysfunction: Con.
    J Urol. 2016 Dec 17. pii: S0022-5347(16)31775-X. doi: 10.1016/j.juro.2016.
    PubMed    


  134. CLAVIJO RI, Ramasamy R
    Testosterone Replacement Should be Given to Men with Erectile Dysfunction: Pro.
    J Urol. 2016 Dec 17. pii: S0022-5347(16)31774-8. doi: 10.1016/j.juro.2016.
    PubMed    


    November 2016
  135. SEFTEL AD
    Re: Vasculogenesis and Diabetic Erectile Dysfunction: How Relevant is Glycemic Control?
    J Urol. 2016;196:1588.
    PubMed    


  136. SEFTEL AD
    Re: The Effects of Adipose-Derived Stem Cells in a Rat Model of Tobacco-Associated Erectile Dysfunction.
    J Urol. 2016;196:1587-1588.
    PubMed    


    October 2016
  137. SEFTEL AD
    Re: Recovery of Baseline Erectile Function in Men following Radical Prostatectomy for High-Risk Prostate Cancer: A Prospective Analysis Using Validated Measures.
    J Urol. 2016;196:1228-30.
    PubMed    


    September 2016
  138. BOZORGMEHRI S, Fink HA, Parimi N, Canales B, et al
    Association of Sleep-Disordered Breathing With Erectile Dysfunction In Community-Dwelling Older Men.
    J Urol. 2016 Sep 30. pii: S0022-5347(16)31408-2. doi: 10.1016/j.juro.2016.
    PubMed     Abstract available


  139. SEFTEL AD
    Re: Vascular and Chronological Age in Men with Erectile Dysfunction: A Longitudinal Study.
    J Urol. 2016;196:857-8.
    PubMed    


  140. SEFTEL AD
    Re: A Nationwide Population-Based Cohort Study of Migraine and Organic-Psychogenic Erectile Dysfunction.
    J Urol. 2016;196:857.
    PubMed    


    August 2016
  141. SEFTEL AD
    Re: Six Months of Daily Treatment with Vardenafil Improves Parameters of Endothelial Inflammation and of Hypogonadism in Male Patients with Type 2 Diabetes and Erectile Dysfunction: A Randomized, Double-Blind, Prospective Trial.
    J Urol. 2016;196:518-9.
    PubMed    


  142. SEFTEL AD
    Re: Tadalafil 5 mg Once Daily for the Treatment of Erectile Dysfunction during a 6-Month Observational Study (EDATE): Impact of Patient Characteristics and Comorbidities.
    J Urol. 2016;196:515-6.
    PubMed    


  143. MOREY AF
    Re: The Vascular and Neurogenic Factors Associated with Erectile Dysfunction in Patients after Pelvic Fractures.
    J Urol. 2016;196:462-3.
    PubMed    


    July 2016
  144. KAPLAN SA, Griebling TL
    Re: The Co-Occurring Syndrome-Coexisting Erectile Dysfunction and Benign Prostatic Hyperplasia and Their Clinical Correlates in Aging Men: Results from the National Health and Nutrition Examination Survey.
    J Urol. 2016;196:190-1.
    PubMed    


    June 2016
  145. SEFTEL AD
    Re: Effect of Levitra on Sustenance of Erection (EROS): An Open-Label, Prospective, Multicenter, Single-Arm Study to Investigate Erection Duration Measured by Stopwatch with Flexible Dose Vardenafil Administered for 8 Weeks in Subjects with Erectile D
    J Urol. 2016;195:1854-6.
    PubMed    


    May 2016
  146. MOREY AF
    Re: Penile Prosthesis First and Replacement Surgeries: Analysis of Patient and Partner Satisfaction.
    J Urol. 2016;195:1510.
    PubMed    


  147. MOREY AF
    Re: The Prevention and Management of Noninfectious Complications of Penile Implants.
    J Urol. 2016;195:1509-10.
    PubMed    


  148. KITREY ND, Gruenwald I, Appel B, Shechter A, et al
    Penile Low Intensity Shock Wave Treatment is Able to Shift PDE5i Nonresponders to Responders: A Double-Blind, Sham Controlled Study.
    J Urol. 2016;195:1550-5.
    PubMed     Abstract available


    April 2016
  149. WHITSON JM, Murray KS, Thrasher JB
    Prostate Biopsy is Associated with an Increased Risk of Erectile Dysfunction.
    J Urol. 2016 Apr 8. pii: S0022-5347(16)30136-7. doi: 10.1016/j.juro.2016.
    PubMed    


  150. JAMNAGERWALLA J, Howard LE, Vidal AC, Moreira DM, et al
    The Association Between Phosphodiesterase Type-5 Inhibitors and Prostate Cancer: Results from the REDUCE Study.
    J Urol. 2016 Apr 5. pii: S0022-5347(16)30127-6. doi: 10.1016/j.juro.2016.
    PubMed     Abstract available


  151. SEFTEL AD
    Re: Intraoperative Decision-Making for Precise Penile Straightening during Inflatable Penile Prosthesis Surgery.
    J Urol. 2016;195.
    PubMed    


  152. SEFTEL AD
    Re: The Importance of Psychosexual Counselling in the Re-Establishment of Organic and Erotic Functions after Penile Prosthesis Implantation.
    J Urol. 2016;195.
    PubMed    


    March 2016
  153. SEFTEL AD
    Re: Erectile Dysfunction in 1050 Men following Extended (18 Cores) vs Saturation (28 Cores) vs Saturation plus MRI-Targeted Prostate Biopsy (32 Cores).
    J Urol. 2016;195:714-5.
    PubMed    


  154. SEFTEL AD
    Re: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
    J Urol. 2016;195:713-5.
    PubMed    


  155. SEFTEL AD
    Re: Unexpected Long-Term Improvements in Urinary and Erectile Function in a Large Cohort of Men with Self-Reported Outcomes following Radical Prostatectomy.
    J Urol. 2016;195:713-4.
    PubMed    


    February 2016
  156. CADEDDU JA
    Re: Urinary Incontinence and Erectile Dysfunction after Robotic versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial.
    J Urol. 2016;195:354.
    PubMed    


  157. MOREY AF
    Re: Prospective Evaluation of Postoperative Penile Rehabilitation: Penile Length/Girth Maintenance 1 Year following Coloplast Titan Inflatable Penile Prosthesis.
    J Urol. 2016;195:444.
    PubMed    


  158. EBERT AK
    Editorial Comment.
    J Urol. 2016;195:470.
    PubMed    


  159. RUBENWOLF P, Thomas C, Thuroff JW, Stein R, et al
    Sexual Function, Social Integration and Paternity of Males with Classic Bladder Exstrophy following Urinary Diversion.
    J Urol. 2016;195:465-70.
    PubMed     Abstract available


  160. HENRY GD, Karpman E, Brant W, Christine B, et al
    The Who, How and What of Real-World Penile Implantation in 2015: The PROPPER Registry Baseline Data.
    J Urol. 2016;195:427-33.
    PubMed     Abstract available


    January 2016
  161. LOEB S, Lambe M, Stattin P
    Re: Editorial Comment on Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma: D. F. Penson J Urol 2015;194:1710-1711.
    J Urol. 2016 Jan 16. pii: S0022-5347(15)05310-0. doi: 10.1016/j.juro.2015.
    PubMed    


  162. SEFTEL AD
    Re: Finasteride, Not Tamsulosin, Increases Severity of Erectile Dysfunction and Decreases Testosterone Levels in Men with Benign Prostatic Hyperplasia.
    J Urol. 2016;195:139.
    PubMed    


    December 2015
  163. PENSON DF
    Re: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
    J Urol. 2015;194:1710-1711.
    PubMed    


  164. SEFTEL AD
    Re: Increased Risk of Dementia in Patients with Erectile Dysfunction: A Population-Based, Propensity Score-Matched, Longitudinal Follow-up Study.
    J Urol. 2015;194:1708-1709.
    PubMed    


  165. SEFTEL AD
    Re: Sex Offenders Seeking Treatment for Sexual Dysfunction--Ethics, Medicine, and the Law.
    J Urol. 2015;194:1708.
    PubMed    


    November 2015
  166. PEYTON CC, Colaco MA, Kovell RC, Kim JH, et al
    Erectile Dysfunction is Predictive of Endothelial Dysfunction in a Well-Visit Population.
    J Urol. 2015 Nov 22. pii: S0022-5347(15)05259-3. doi: 10.1016/j.juro.2015.
    PubMed     Abstract available


  167. SEFTEL AD
    Re: Evaluation of Clinical Efficacy, Safety and Patient Satisfaction Rate after Low-Intensity Extracorporeal Shockwave Therapy for the Treatment of Male Erectile Dysfunction: An Australian First Open-Label Single-Arm Prospective Clinical Trial.
    J Urol. 2015;194:1364.
    PubMed    


  168. SILVA CN, Nunes KP, Torres FS, Cassoli JS, et al
    PnPP-19, a Synthetic and Nontoxic Peptide Designed from a Phoneutria nigriventer Toxin, Potentiates Erectile Function via NO/cGMP.
    J Urol. 2015;194:1481-90.
    PubMed     Abstract available


    October 2015
  169. LIN H, Dhanani N, Tseng H, Souza GR, et al
    Nanoparticle Improved Stem Cell Therapy for Erectile Dysfunction in a Rat Model of Cavernous Nerve Injury.
    J Urol. 2015 Oct 28. pii: S0022-5347(15)05149-6. doi: 10.1016/j.juro.2015.
    PubMed     Abstract available


    July 2015
  170. SEFTEL AD
    Re: A Randomised Controlled Trial of a Couples-Based Sexuality Intervention for Men with Localised Prostate Cancer and their Female Partners.
    J Urol. 2015;194:167-8.
    PubMed    


    May 2015
  171. ZILLI T, Miralbell R
    Re: Prophylactic Sildenafil Citrate Improves Select Aspects of Sexual Function in Men Treated with Radiotherapy for Prostate Cancer: M. J. Zelefsky, D. Shasha, R. D. Branco, M. Kollmeier, R. E. Baser, X. Pei, R. Ennis, R. Stock, N. Bar-Chama and J. P.
    J Urol. 2015 May 6. pii: S0022-5347(15)03228-0. doi: 10.1016/j.juro.2014.
    PubMed    


  172. KAPLAN SA
    Re: Patient-reported sexual outcomes after holmium laser enucleation of the prostate: a 3-year follow-up study.
    J Urol. 2015;193:1604-5.
    PubMed    


    April 2015
  173. SEFTEL AD
    Re: Effects of holmium laser enucleation of the prostate on sexual function.
    J Urol. 2015;193:1326-7.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Erectile Dysfunction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: